• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number CDS0701-XT
Device Problems Off-Label Use (1494); Incomplete Coaptation (2507)
Patient Problem Tricuspid Regurgitation (2112)
Event Date 12/31/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report post procedure,a single leaflet device attachment and recurrent mr occurred.It was reported that this was a mitraclip procedure on 12/30/2020 to treat tricuspid regurgitation (tr) with grade 4+.One clip was implanted on the anterior and septal leaflets, reducing tr to 2.Imaging was poor during the procedure.The next day, the transthoracic echocardiography showed tr returned to a grade 4.A single leaflet device attachment was noted.There was no tissue damage noted.There was no additional treatment performed or planned.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents reported from this lot.A cause for the reported single leaflet device attachment (slda) could not be determined.The reported recurrent tricuspid regurgitation (tr) appears to have been a result of the slda.A cause for the reported poor imaging could not be determined.It should be noted that per the mitraclip system instructions for use states: ¿the mitraclip¿ g4 system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation (mr)." based on the available information, the reported off-label use was due to the device being used on a tricuspid valve.However, it cannot be confirmed in this case if the off-label use contributed to the reported slda.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11164399
MDR Text Key226619929
Report Number2024168-2021-00404
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648230981
UDI-Public08717648230981
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/18/2021
Device Model NumberCDS0701-XT
Device Catalogue NumberCDS0701-XT
Device Lot Number00818U231
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/31/2020
Initial Date FDA Received01/13/2021
Supplement Dates Manufacturer Received01/13/2021
Supplement Dates FDA Received01/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-